Literature DB >> 19020415

Increased elevated plus maze open-arm time in mice during naloxone-precipitated morphine withdrawal.

Stephen R Hodgson1, Rebecca S Hofford, Chris J Norris, Shoshana Eitan.   

Abstract

Opioid withdrawal is known to be anxiogenic in humans and, using the elevated plus maze (EPM), was demonstrated to also be anxiogenic in rats. Thus, this study characterizes EPM behaviors of mice during naloxone-precipitated morphine withdrawal. Naloxone did not significantly change EPM behaviors of drug-naïve mice. Additionally, morphine-dependent mice in which withdrawal was not precipitated (i.e. morphine-dependent mice receiving saline) spent less time in the open-arms compared to the controls. Surprisingly, increased open-arm time was observed in morphine-dependent mice undergoing naloxone-precipitated withdrawal. This increase was not because of total motor activity, as no significant differences in total activity were observed. Moreover, morphine dependency was necessary, given that there was not a significant increase in open-arm time for mice undergoing withdrawal from acute morphine. Increased open-arm time during withdrawal is unexpected, given that opioid withdrawal is usually associated with anxiety. Additionally, even in mice, naloxone-precipitated morphine withdrawal is known be aversive and increases plasma corticosterone levels. In conclusion, this study demonstrates somewhat unexpected EPM behavior in mice undergoing naloxone-precipitated morphine withdrawal. Possible interpretations of these EPM results, though somewhat speculative, raise the possibility that EPM behaviors might not be driven exclusively by anxiety levels but rather by other withdrawal-induced behaviors.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19020415     DOI: 10.1097/FBP.0b013e32831c3b57

Source DB:  PubMed          Journal:  Behav Pharmacol        ISSN: 0955-8810            Impact factor:   2.293


  7 in total

1.  Social influences on morphine sensitization in adolescent females.

Authors:  Rebecca S Hofford; Kris W Roberts; Paul J Wellman; Shoshana Eitan
Journal:  Drug Alcohol Depend       Date:  2010-04-24       Impact factor: 4.492

2.  Increased opioid dependence in a mouse model of panic disorder.

Authors:  Xavier Gallego; Patricia Murtra; Teresa Zamalloa; Josep Maria Canals; Joseba Pineda; Alejandro Amador-Arjona; Rafael Maldonado; Mara Dierssen
Journal:  Front Behav Neurosci       Date:  2010-02-22       Impact factor: 3.558

3.  Socially induced morphine pseudosensitization in adolescent mice.

Authors:  Stephen R Hodgson; Rebecca S Hofford; Kris W Roberts; Paul J Wellman; Shoshana Eitan
Journal:  Behav Pharmacol       Date:  2010-03       Impact factor: 2.293

4.  Timing of amphetamine exposure in relation to puberty onset determines its effects on anhedonia, exploratory behavior, and dopamine D1 receptor expression in young adulthood.

Authors:  Shuo Kang; Mariah M Wu; Roberto Galvez; Joshua M Gulley
Journal:  Neuroscience       Date:  2016-10-01       Impact factor: 3.590

5.  Attenuation by baclofen of nicotine rewarding properties and nicotine withdrawal manifestations.

Authors:  Andrés P Varani; Ester Aso; Lirane Machado Moutinho; Rafael Maldonado; Graciela N Balerio
Journal:  Psychopharmacology (Berl)       Date:  2014-02-20       Impact factor: 4.530

6.  Extracellular signal-regulated kinase activation in the amygdala mediates elevated plus maze behavior during opioid withdrawal.

Authors:  Rebecca S Hofford; Stephen R Hodgson; Kris W Roberts; Camron D Bryant; Christopher J Evans; Shoshana Eitan
Journal:  Behav Pharmacol       Date:  2009-10       Impact factor: 2.293

7.  Reproductive experience modifies the effects of estrogen receptor alpha activity on anxiety-like behavior and corticotropin releasing hormone mRNA expression.

Authors:  Elizabeth M Byrnes; Kerriann Casey; Robert S Bridges
Journal:  Horm Behav       Date:  2011-10-18       Impact factor: 3.587

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.